Shinpoon Pharm and WHO to jointly develop anti-malarial drug

Published: 2002-07-15 06:57:00
Updated: 2002-07-15 06:57:00
Shinpoong Pharm announced on July 9 that it will jointly develop a novel anti-malarial drug in a tablet form until 2004 with the World Health Organization (WHO).

To that end, Shinpoong Pharm is to receive a $11.92 million grant from the MNV Foundation of Chairman Bill Gates, Microsoft of the ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.